Related Experiment Video
Updated: Jan 31, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
Current Practice and Safety of Invasive Coronary Function Testing: A Nationwide Multicenter Survey in Japan
Takeshi Nishi1, Michikazu Nakai2, Masanobu Ishii3
1Department of Cardiovascular Medicine, Chiba University Graduate School Medicine, Chiba, Japan; Department of Cardiology, Kawasaki Medical School, Kurashiki, Japan.
Insights
Coronary function testing (CFT) is safe and feasible for diagnosing coronary vasomotor dysfunction, even in emergencies. This study supports wider use of CFT for ischemia or myocardial infarction with nonobstructive coronary arteries (INOCA/MINOCA).
Area of Science:
- Cardiology
- Interventional Cardiology
- Diagnostic Testing
Background:
- Coronary vasomotor dysfunction, including vasospastic angina and coronary microvascular dysfunction, is a primary cause of INOCA/MINOCA.
- Invasive coronary function testing (CFT) offers diagnostic value but its real-world application and safety, particularly in emergency situations, require further evaluation.
Purpose of the Study:
- To evaluate the current practices, diagnostic yield, and safety of CFT in Japan.
- To assess acetylcholine (ACh) and ergonovine (ERG) provocation tests, and coronary microvascular assessments (CFR/IMR).
Main Methods:
- A nationwide cross-sectional survey of 235 institutions in Japan.
- Data collection on procedure volume, positivity rates, and complications for CFT performed between January 2022 and December 2023.
Main Results:
- Over 6,900 provocation tests (ACh and ERG) and 2,100 CFR/IMR assessments were analyzed.
- Positivity rates were 50.9% for ACh and 32.5% for ERG; major complications were rare (1.4% for ACh, 0.4% for ERG).
- Abnormal microvascular findings were more frequent in emergency cases, with low complication rates (0.05%).
Conclusions:
- Invasive CFT is feasible and safe, including in emergency settings for diagnosing INOCA/MINOCA.
- The findings support the expanded use of CFT in clinical practice for patients with suspected coronary vasomotor dysfunction.
Background:
Coronary vasomotor dysfunction-including vasospastic angina and coronary microvascular dysfunction-is a key mechanism underlying ischemia or myocardial infarction with nonobstructive coronary arteries (INOCA/MINOCA). While invasive coronary function testing (CFT) provides important diagnostic insights, its real-world use and safety-especially in emergency settings-remain poorly defined.
Objectives:
The purpose of this study was to assess the current practice, diagnostic yield, and safety of CFT, including acetylcholine (ACh) and ergonovine (ERG) provocation tests and coronary microvascular assessments using coronary flow reserve (CFR) and index of microcirculatory resistance (IMR), in Japan.
Methods:
We conducted a nationwide cross-sectional survey of 235 institutions affiliated with the Japanese Cardiovascular Intervention and Therapeutics Society. Data on procedure volume, positivity rates, and complications were collected for tests performed between January 2022 and December 2023.
Results:
Among 6,983 provocation tests, 4,700 were ACh (4,327 elective and 373 emergency) and 2,283 were ERG (2,009 elective and 274 emergency). CFR/IMR was measured in 2,192 cases. Positivity rates were 50.9% for ACh and 32.5% for ERG. Major complications occurred in 1.4% of ACh and 0.4% of ERG tests, with no significant difference between emergency and elective settings. Abnormal CFR/IMR findings were more common in emergency cases (45.9% vs 34.8%; P < 0.001), while complications remained rare (0.05%).
Conclusions:
This large-scale survey confirms the feasibility and safety of invasive CFT, even in emergency settings. These findings support its broader adoption in the diagnostic workup of INOCA and MINOCA.
More Related Videos
Related Concept Videos
Survey Safety
Surveys
Introduction to Surveying, Plane Surveying and Geodetic Surveys
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Errors and Mistakes in Surveying
Types of Surveys

